Sinovac for 3-year-olds? Hong Kong parents should have BioNTech option as well, pharmacists group chief says

Hong Kong parents should also have the option of BioNTech jabs for their younger children, the head of the city's pharmacists association has suggested ahead of a Monday (Nov 15) meeting expected to determine if children as young as three will be allowed to take the Sinovac vaccine. Sinovac's mainland Chinese manufacturer last month applied to...

The United States Opens Its Borders To Fully Vaccinated Travellers Without Quarantine

More countries are reopening their borders to international tourists following the progress of the worldwide vaccination rates.  After shutting its border closed for nearly 20 months, the United States of America (USA) has now opened its door to international travellers, including from Malaysia. Of course, you have to be fully vaccinated to travel abroad. According to BFM News, The US Embassy in...

Moderna struggles with vaccine ramp-up, cuts 2021 sales view

Moderna Inc on Thursday (Nov 4) slashed the 2021 sales forecast for its Covid-19 vaccine by as much as $5 billion (S$6.7 billion), grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16 per cent. Moderna executives said production challenges now lie with bottling up doses, also known as...

Pfizer/BioNTech Covid-19 vaccine highly protective in 12-18 age group: US CDC study

The Pfizer/BioNTech vaccine is authorised for children as young as 12, and the companies are seeking authorisation for use in those as young as five years of age.Reuters WASHINGTON - The Pfizer/BioNTech Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the US Centres...

Covid-19 pill developers aim to top Merck, Pfizer efforts

An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP.Reuters file As Merck & Co and Pfizer Inc prepare to report clinical trial results for experimental Covid-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their...

Moderna withholds 1.63 million Covid-19 vaccine doses in Japan due to contamination

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken on Oct 31, 2020.Reuters file Moderna Inc has withheld supply of about 1.63 million doses in Japan after it was notified of contamination of its Covid-19 vaccine vials...

Coronavirus: Early signs Sinovac’s jab is safe and effective in children

The Covid-19 vaccine developed by Chinese company Sinovac is safe and effective for children as young as three, early stage human trials have found, as China seeks to expand immunisation coverage. The vaccine, which gained World Health Organisation emergency use approval for adults earlier this month, has already been approved for emergency use for children above...

Malaysia to procure 12.8m more doses of Pfizer-BioNTech vaccine

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken Oct 31, 2020.Reuters Malaysia will procure an additional 12.8 million doses of coronavirus vaccine jointly developed by Pfizer and BioNTech in a bid to ramp up its...

German researchers tie cold viruses used to deliver Covid-19 vaccine to rare blood clot risk

A new paper suggests that vaccine makers using adenovirus vectors could modify the sequence of the spike protein.Reuters German researchers on Wednesday (May 26) said that based on laboratory research, they believed they have found the cause of the rare but serious blood-clotting events among some people who received Covid-19 vaccines made by AstraZeneca and Johnson...

Sinopharm’s 2 Covid-19 vaccines show over 70% efficacy against symptomatic cases: Study

A nurse prepares a dose of China's Sinopharm coronavirus disease (Covid-19) vaccine at a health center in Caracas, Venezuela, on March 7, 2021.Reuters Two Covid-19 vaccines from China's Sinopharm showed more than 70 per cent efficacy against symptomatic cases, but it remains unclear how much protection they provide against severe or asymptomatic cases, according to the...